MTA limits tumor growth by inhibiting three metabolic enzymes, e.g., the folate-dependent enzymes thymidylate synthase (TS) and dihydrofolate reductase (DHFR), and the purine biosynthetic enzyme, glycinamide ribonucleotide formyltransferase (GARFT) [5]. This evidence concerns the gene DHFR and neoplasm.